Envestnet Asset Management’s Immunomedics Inc IMMU Stock Holding History

Envestnet Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-66,120	Closed	-$5.62M	–	3384
2020 Q3	$5.62M	Sell	66,120 -4,462	-6%	-$226K	0.01%	1105
2020 Q2	$2.5M	Buy	70,582 +2,890	+4%	+$84.5K	﹤0.01%	1450
2020 Q1	$912K	Sell	67,692 -14,626	-18%	-$246K	﹤0.01%	1874
2019 Q4	$1.74M	Buy	82,318 +37,443	+83%	+$661K	﹤0.01%	1687
2019 Q3	$595K	Buy	44,875 +1,834	+4%	+$27K	﹤0.01%	2268
2019 Q2	$597K	Buy	43,041 +1,127	+3%	+$17K	﹤0.01%	2283
2019 Q1	$805K	Buy	+41,914	New	+$676K	﹤0.01%	2030
2016 Q2	–	Sell	-11,539	Closed	-$29K	–	3161
2016 Q1	$29K	Buy	+11,539	New	+$25.9K	﹤0.01%	2890

Envestnet Asset Management's IMMU Position: Q4 2020 in Review

Envestnet Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 66,120 shares — an estimated $5.62M sold.

Envestnet Asset Management first reported a position in IMMU in Q1 2016 and held it in 8 quarters. The position peaked at $5.62M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Envestnet Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Envestnet Asset Management sold 66,120 Immunomedics Inc shares in Q4 2020, an estimated $5.62M.
Envestnet Asset Management first reported a position in Immunomedics Inc in Q1 2016 and held it in 8 quarters.
Envestnet Asset Management's Immunomedics Inc position peaked at $5.62M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Envestnet Asset Management's 13F filing for Q4 2020, filed 2 Feb 2021.